We are live on ! Find out more
WGS icon

GeneDx Holdings
WGS

268 hedge funds and large institutions have $3.24B invested in GeneDx Holdings in 2025 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 86 increasing their positions, 82 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 31

16% more funds holding

Funds holding: 231 → 268 (+37)

12% more capital invested

Capital invested by funds: $2.91B → $3.24B (+$335M)

5% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 82

0% more funds holding in top 10

Funds holding in top 10: 11 → 11 (0)

5.62% less ownership

Funds ownership: 110.41% → 104.79% (-5.6%)

26% less call options, than puts

Call options by funds: $122M | Put options by funds: $164M

Holders
268
Holders Change
+37
Holders Change %
+16.02%
% of All Funds
3.52%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
69
Increased
86
Reduced
82
Closed
31
Calls
$122M
Puts
$164M
Net Calls
-$42.2M
Net Calls Change
-$1.09M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$48.7M
2
Franklin Resources
Franklin Resources
California
+$37.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$37M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$34.5M
5
NAMA
Nikko Asset Management Americas
New York
+$31.8M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$92.8M
2
PCM
Pentwater Capital Management
Florida
-$86.6M
3
CC
Casdin Capital
New York
-$54.5M
4
FAM
Fred Alger Management
New York
-$50.5M
5
William Blair Investment Management
William Blair Investment Management
Illinois
-$44.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
201
Oppenheimer Asset Management
New York
$206K -$70.5K -647 -25%
CIP
202
Cornerstone Investment Partners
Georgia
$205K +$208K +1,906 New
PA
203
PharVision Advisers
Florida
$202K +$205K +1,879 New
OAM
204
OP Asset Management
$202K +$205K +1,877 New
SOADOR
205
State of Alaska Department of Revenue
Alaska
$187K +$189K +1,737 New
SO
206
STRS Ohio
Ohio
$172K -$131K -1,200 -43%
RA
207
RiverPark Advisors
New York
$170K -$48.4K -444 -22%
AIP
208
Ameritas Investment Partners
Nebraska
$169K -$37.9K -348 -18%
A
209
AlphaQuest
New York
$140K +$58.8K +540 +71%
US Bancorp
210
US Bancorp
Minnesota
$125K -$44.2K -406 -26%
N
211
Natixis
France
$86.2K +$87.2K +800 New
GCS
212
Gordian Capital (Singapore)
Singapore
$64.6K +$65.4K +600 New
KBC Group
213
KBC Group
Belgium
$54K – – –
Rockefeller Capital Management
214
Rockefeller Capital Management
New York
$53.9K +$54.5K +500 New
CAL
215
Capital Advisors Ltd
Ohio
$50K – – –
VCM
216
Versant Capital Management
Arizona
$49K – – –
AB
217
Amalgamated Bank
New York
$48K – – –
BL
218
Bleichroeder LP
New York
$32.8K – – –
QL
219
Quarry LP
New York
$31.6K +$22.8K +209 +249%
MA
220
MCF Advisors
Kentucky
$28.9K +$1.09K +10 +4%
GI
221
GAMMA Investing
California
$26.8K +$4.03K +37 +17%
AWM
222
Activest Wealth Management
Florida
$25.9K – – –
Jones Financial Companies
223
Jones Financial Companies
Missouri
$25.1K +$20.3K +186 +664%
WSFS
224
Wilmington Savings Fund Society
Delaware
$21.5K – – –
BNP Paribas Asset Management
225
BNP Paribas Asset Management
France
$20K – – –
7 8
9
10 11

WGS Hedge Fund Activity: Q3 2025 in Review

268 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q3 2025, worth a combined $3.24B — up 12% from $2.91B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new WGS positions and 31 closed out — a net gain of 38 holders — while 86 added to existing stakes and 82 trimmed.

The largest buyer was ARK Investment Management, opening a new position worth an estimated $48.7M. The largest seller was UBS Group, cutting an estimated $92.8M.

  • 268 institutional investors held GeneDx Holdings (WGS) as of Q3 2025, up from 231 in Q2 2025.
  • Funds reported $3.24B of GeneDx Holdings stock for Q3 2025, up 12% quarter-over-quarter.
  • 69 funds opened new GeneDx Holdings positions in Q3 2025 and 31 closed out, a net change of +38 holders.
  • The largest GeneDx Holdings buyer in Q3 2025 was ARK Investment Management, an estimated $48.7M added.
  • The largest GeneDx Holdings seller in Q3 2025 was UBS Group, an estimated $92.8M sold.

Based on aggregated 13F filings for Q3 2025.